Circular RNA circ_0067741 regulates the Hippo/YAP pathway to suppress lung adenocarcinoma progression by targeting microRNA-183-5p

References

• Siegel RL, Miller KD, Fuchs HE, et al. Cancer STATISTICS, 2021. CA Cancer J Clin. 2021;71(1):7–33.
   PubMed Web of Science ®Google Scholar
• Myers DJ, Wallen JM. Lung Adenocarcinoma 2021 Sep 10, StatPearls [Internet].Treasure Island (FL): StatPearls Publishing, 2022 Jan-.
   Google Scholar
• Ferlay J, Colombet M, Soerjomataram I, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019;144(8):1941–1953.
   PubMed Web of Science ®Google Scholar
• Hong QY, Wu GM, Qian GS, et al. Prevention and management of lung cancer in China. Cancer. 2015;121(17):3080–3088.
   PubMedGoogle Scholar
• Zhao J, Li L, Wang Q, et al. CircRNA expression profile in early-stage lung adenocarcinoma patients. Cell Physiol Biochem. 2017;44(6):2138–2146.
   PubMedGoogle Scholar
• Salzman J, Gawad C, Wang PL, et al. Circular RNAs are the predominant transcript isoform from hundreds of human genes in diverse cell types. PLoS One. 2012;7(2):e30733.
   PubMed Web of Science ®Google Scholar
• Lasda E, Parker R. Circular RNAs: diversity of form and function. Rna. 2014;20(12):1829–1842.
   PubMed Web of Science ®Google Scholar
• Jeck WR, Sorrentino JA, Wang K, et al. Circular RNAs are abundant, conserved, and associated with ALU repeats. Rna. 2013;19:141–157.
   PubMed Web of Science ®Google Scholar
• Memczak S, Jens M, Elefsinioti A, et al. Circular RNAs are a large class of animal RNAs with regulatory potency. Nature. 2013;495(7441):333–338.
   PubMed Web of Science ®Google Scholar
• Hansen TB, Jensen TI, Clausen BH, et al. Natural RNA circles function as efficient microRNA sponges. Nature. 2013;495(7441):384–388.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhang XO, Chen T, et al. Circular intronic long noncoding RNAs. Mol Cell. 2013;51(6):792–806.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Sun Y, Wang C, et al. Circular RNA-microRNA-mRNA network identified circ_0007618 and circ_0029426 as new valuable biomarkers for lung adenocarcinoma. Bioengineered. 2022;13(3):6258–6271.
   PubMed Web of Science ®Google Scholar
• Ma D, Liu H, Qin Y, et al. Circ_0007142/miR-186/FOXK1 axis promoted lung adenocarcinoma progression. Am J Transl Res. 2020;12(8):4728–4738.
   PubMed Web of Science ®Google Scholar
• Xin T, Li S, Zhang Y, et al. circRNA Hsa_circ_0020850 silence represses the development of lung adenocarcinoma via regulating miR-195-5p/IRS2 axis. Cancer Manag Res. 2020;12:10679–10692.
   PubMed Web of Science ®Google Scholar
• Dambal S, Shah M, Mihelich B, et al. The microRNA-183 cluster: the family that plays together stays together. Nucleic Acids Res. 2015;43(15):7173–7188.
   PubMed Web of Science ®Google Scholar
• Xu F, Zhang H, Su Y, et al. Up-regulation of microRNA-183-3p is a potent prognostic marker for lung adenocarcinoma of female non-smokers. Clin Transl Oncol. 2014;16(11):980–985.
   PubMed Web of Science ®Google Scholar
• Wang R, Li Y, Hu E, et al. S100A7 promotes lung adenocarcinoma to squamous carcinoma transdifferentiation, and its expression is differentially regulated by the Hippo-YAP pathway in lung cancer cells. Oncotarget. 2017;8(15):24804–24814.
   PubMedGoogle Scholar
• Ma Y, Yang Y, Wang F, et al. Hippo-YAP signaling pathway: a new paradigm for cancer therapy. Int J Cancer. 2015;137(10):2275–2286.
   PubMed Web of Science ®Google Scholar
• Salem O, Hansen CG. The hippo pathway in prostate cancer. Cells. 2019;8(4):370.
   PubMed Web of Science ®Google Scholar
• Lee KY, Kuo TC, Chou CM, et al. Upregulation of CD109 promotes the epithelial-to-mesenchymal transition and stemness properties of lung adenocarcinomas via activation of the hippo-YAP signaling. Cells. 2020;10(1):28.
   PubMed Web of Science ®Google Scholar
• He Z, Wang X, Huang C, et al. The FENDRR/miR-214-3P/TET2 axis affects cell malignant activity via RASSF1A methylation in gastric cancer. Am J Transl Res. 2018;10(10):3211–3223.
   PubMed Web of Science ®Google Scholar
• Zou P, Zhu M, Lian C, et al. miR-192-5p suppresses the progression of lung cancer bone metastasis by targeting TRIM44. Sci Rep. 2019;9(1):19619.
   PubMedGoogle Scholar
• Kawaguchi Y, Hanaoka J, Oshio Y, et al. Decrease in performance status after lobectomy mean poor prognosis in elderly lung cancer patients. J Thorac Dis. 2017;9(6):1525–1530.
   PubMed Web of Science ®Google Scholar
• Rossi A, Sacco PC, Santabarbara G, et al. Developments in pharmacotherapy for treating metastatic non-small cell lung cancer. Expert Opin Pharmacother. 2017;18(2):151–163.
   PubMed Web of Science ®Google Scholar
• Li WH, Song YC, Zhang H, et al. Decreased expression of Hsa_circ_00001649 in gastric cancer and its clinical significance. Dis Markers. 2017;2017:4587698.
   PubMed Web of Science ®Google Scholar
• Yan Y, Zhang R, Zhang X, et al. RNA-Seq profiling of circular RNAs and potential function of hsa_circ_0002360 in human lung adenocarcinom. Am J Transl Res. 2019;11(1):160–175.
   PubMed Web of Science ®Google Scholar
• Dou Y, Cha DJ, Franklin JL, et al. Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes. Sci Rep. 2016;6(1):37982.
   PubMed Web of Science ®Google Scholar
• Meng F, Zhang L. miR-183-5p functions as a tumor suppressor in lung cancer through PIK3CA inhibition. Exp Cell Res. 2019;374(2):315–322.
   PubMed Web of Science ®Google Scholar
• Wang H, Ma Z, Liu X, et al. MiR-183-5p is required for non-small cell lung cancer progression by repressing PTEN. Biomed Pharmacother. 2019;111:1103–1111.
   PubMed Web of Science ®Google Scholar
• Wang Q, He F, Liu Q, et al. Effects of TNF-α on proliferation and apoptosis of colon cancer cells by regulating expression of miR-650/LATS1 and its mechanism. Chinese J Immunol. 2020;36:699–706.
   Google Scholar
• Zhang J, Wang G, Chu SJ, et al. Loss of large tumor suppressor 1 promotes growth and metastasis of gastric cancer cells through upregulation of the YAP signaling. Oncotarget. 2016;7(13):16180–16193.
   PubMedGoogle Scholar
• Chen KH, Wang DL. Lats1 is the key component of hippo signaling pathway: a new tumor molecular biomarker and a potential therapeutic target. Chin J Cell Biol. 2015;37:256–262.
   Google Scholar
• Shen S, Guo X, Yan H, et al. A miR-130a-YAP positive feedback loop promotes organ size and tumorigenesis. Cell Res. 2015;25(9):997–1012.
   PubMed Web of Science ®Google Scholar
• Tan G, Cao X, Dai Q, et al. A novel role for microRNA-129-5p in inhibiting ovarian cancer cell proliferation and survival via direct suppression of transcriptional co-activators YAP and TAZ. Oncotarget. 2015;6(11):8676–8686.
   PubMedGoogle Scholar